Para citar este trabalho use um dos padrões abaixo:
Introduction: Melanoma is an aggressive skin neoplasm with high metastatic potential, whose progression is sustained by chronic inflammation of the tumor microenvironment, which favors proliferation, invasion, and immune evasion. Conventional therapies may be limited mainly by resistance and adverse effects, which motivates the search for new approaches. In this context, resveratrol (RVT), a phytoalexin found in grape skin, stands out for its anti-inflammatory and antitumor properties, although its clinical application is limited by low bioavailability. RVT analogs, such as AR26, previously characterized as anti-inflammatory, emerge as a promising strategy to act on both the tumor and inflammatory components of cancer. This study aims to evaluate the antitumor potential of AR26 in murine and human melanoma cells. Methods: The melanoma cell lines B16-F10 (murine) and SK-MEL-28 (human) were used, as well as human keratinocytes (HaCaT) and murine fibroblasts (L929). Viability was assessed by MTT, proliferation by CFSE dilution, and migration by wound healing assay. SK-MEL-28 spheroids were used to evaluate growth and migration after treatment withdrawal. Results: AR26 showed moderate cytotoxicity against melanoma cells and a favorable biocompatibility profile in non-tumor cells. At 100 µM, it significantly inhibited melanoma cell migration and promoted intense inhibition of proliferation. Although it did not alter spheroid size, pretreatment with AR26 decreased migration after compound withdrawal, with an effect superior to that of RVT. Conclusion: The data indicate that AR26, in addition to being anti-inflammatory, has relevant antiproliferative and antimigratory activity, with good biocompatibility. Co-culture studies of macrophages and melanoma cells will evaluate its impact on the interaction between inflammation and tumor progression.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo